Viewing StudyNCT00002161



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2025-12-16 @ 4:53 PM
Study NCT ID: NCT00002161
Status: None
Last Update Posted: 2005-06-24 00:00:00
First Post: 1999-11-02 00:00:00

Brief Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3
Sponsor: Gilead Sciences
Organization: NIH AIDS Clinical Trials Information Service

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 1999-11-02 00:00:00
First Submit QC Date: August 30 2001
Study First Post Date: 2001-08-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2005-06-23 00:00:00
Last Update Post Date: 2005-06-24 00:00:00
Last Update Post Date Type: ESTIMATED